SCHEMBL8478346

SCHEMBL8478346

O=C(O)Cc1ccc(OCC(O)CC2CN(CC(=O)O)CCN(CC(=O)O)CCNCCN2CC(=O)O)cc1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.41
EGFR P00533 1/20 0.38
MAPT P10636 1/20 0.38
ALDH1A1 P00352 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MAPK1 P28482 2/20 0.35
ABCB1 P08183 2/20 0.35
CACNA1G O43497 1/20 0.35
KCNH2 Q12809 1/20 0.35
POLB P06746 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HTR7 P34969 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8478317 0.91 ITGB3 (0.41) EGFRMAPTALDH1A1CYP2D6CYP2C9
SCHEMBL8478646 0.91 MAPT (0.39) EGFRMAPTALDH1A1CYP2D6CYP2C9
SCHEMBL8477764 0.91 MAPT (0.41) KDM1AEGFRMAPTALDH1A1CYP2D6
SCHEMBL8482399 0.90 KDM4E (0.41) MAPTALDH1A1CYP2D6MAPK1POLB
SCHEMBL8482595 0.88 S1PR1 (0.37) EGFRMAPTALDH1A1CYP2D6CYP2C9
SCHEMBL8479012 0.80 ESRRG (0.39) EGFRMAPTALDH1A1SMN1; SMN2
SCHEMBL8478663 0.79 EGFR (0.49) EGFRMAPTALDH1A1SMN1; SMN2POLB
SCHEMBL8505444 0.78 CHRM5 (0.30)
SCHEMBL8541479 0.76 MAPT (0.59) KDM1AMAPTALDH1A1CYP2D6CYP2C9
SCHEMBL8478330 0.75 KDM1A (0.39) KDM1AEGFRMAPTALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5871709-A TETRAAZACYCLODODECANE COMPOUNDS SUBSTITUTED WITH ALKYL CARBOXY COMPOUNDS FOR CARDIOVASCULAR DISORDERS AND BRAIN TUMORS SCHERING AKTIENGESELLSCHAFT (DE) 1999-02-16 US disclosed